Limit/Sort Search Search as Words
     
Limit search to available items
Nearby Subjects are:
Result Page   Prev Next
Add Marked to Bag Add All On Page Add Marked to My Lists
Mark   Year Entries
  Inhibitors, Complement -- 2 Related Subjects   2
 

Inhibitors, COX-2 -- See Cyclooxygenase 2 Inhibitors


A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2 		  1
 

Inhibitors, COX2 -- See Cyclooxygenase 2 Inhibitors


A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2 		  1
Cyclic nucleotide phosphodiesterases -- Inhibitors -- Therapeutic use : Oral pharmacotherapy for male sexual dysfunction : a guide to clinical management / edited by Gregory A. Broderick  2005 1
Cyclin-dependent kinases -- Inhibitors : Prognostic and therapeutic applications of RKIP in cancer / edited by Benjamin Bonavida and Stavroula Baritaki  2020 1
Cyclin-dependent kinases -- Inhibitors -- Therapeutic use : Cyclin dependent kinase 5 (Cdk5) / Nancy Y. Ip, Li-Huei Tsai, editors  2008 1
 

Inhibitors, Cyclooxygenase 2 -- See Cyclooxygenase 2 Inhibitors


A subclass of cyclooxygenase inhibitors with specificity for CYCLOOXYGENASE-2 		  1
Cyclooxygenase 2 -- Inhibitors. : Inflammation in the pathogenesis of chronic diseases : the COX-2 controversy / edited by Randall E. Harris  2007 1
Cyclooxygenase 2 -- Inhibitors -- Therapeutic use : Cox-2 : a new target for cancer prevention and treatment / volume editors, Andrew J. Dannenberg, Raymond N. DuBois  2003 1
Cysteine proteinases -- Inhibitors.   3
DNA topoisomerases -- Inhibitors : DNA topoisomerases and cancer / Yves Pommier, editor  2012 1
  Inhibitors, Enzyme -- 2 Related Subjects   2
Epidermal growth factor -- Receptors -- Inhibitors : Third-Generation EGFR Inhibitors : Overcoming EGFR Resistance and Toxicity Problems / Harun M. Patel, Rahul Pawara, Sanjay J. Surana  2019 1
 

Inhibitors, Growth -- See Growth Inhibitors


Endogenous or exogenous substances which inhibit the normal growth of human and animal cells or micro-organisms, as distinguished from those affecting plant growth (= PLANT GROWTH REGULATORS) 		  1
 

Inhibitors, HDAC -- See Histone Deacetylase Inhibitors


Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains 		  1
 

Inhibitors, Histone Deacetylase -- See Histone Deacetylase Inhibitors


Compounds that inhibit HISTONE DEACETYLASES. This class of drugs may influence gene expression by increasing the level of acetylated HISTONES in specific CHROMATIN domains 		  1
Histone deacetylase -- Inhibitors : Histone deacetylase inhibitors in combinatorial anticancer therapy / Shabir Ahmad Ganai  2020 1
HIV (Viruses) -- Enzymes -- Inhibitors : HIV-1 integrase : mechanism and inhibitor design / [edited] by Nouri Neamati  2011 1
 

Inhibitors, HMG-CoA Reductase -- See Hydroxymethylglutaryl-CoA Reductase Inhibitors


Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis 		  1
 

Inhibitors, Hydroxymethylglutaryl-CoA -- See Hydroxymethylglutaryl-CoA Reductase Inhibitors


Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis 		  1
 

Inhibitors, Hydroxymethylglutaryl-CoA Reductase -- See Hydroxymethylglutaryl-CoA Reductase Inhibitors


Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis 		  1
 

Inhibitors, Hydroxymethylglutaryl-Coenzyme A -- See Hydroxymethylglutaryl-CoA Reductase Inhibitors


Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis 		  1
 

Inhibitors, Indirect Thrombin -- See Anticoagulants


Agents that prevent BLOOD CLOTTING 		  1
JNK mitogen-activated protein kinases -- Inhibitors : The JNK signaling pathway / [edited by] Anning Lin  2006 1
 

Inhibitors, Kininase II -- See Angiotensin-Converting Enzyme Inhibitors


A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility 		  1
Leptin -- Inhibitors : Leptin and leptin antagonists / [edited by] Arieh Gertler  2009 1
 

Inhibitors, Lipoxygenase -- See Lipoxygenase Inhibitors


Compounds that bind to and inhibit that enzymatic activity of LIPOXYGENASES. Included under this category are inhibitors that are specific for lipoxygenase subtypes and act to reduce the production of LEUKOTRIENES 		  1
 

Inhibitors, MAO -- See Monoamine Oxidase Inhibitors


A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) 		  1
Metalloproteinases -- Inhibitors   2
 

Inhibitors, Monoamine Oxidase -- See Monoamine Oxidase Inhibitors


A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) 		  1
Monoamine oxidase -- Inhibitors   3
Monoamine oxidase -- Inhibitors -- Congresses : Monoamine Oxidase and its Inhibition  2009 1
Monoamine oxidase -- Inhibitors -- Therapeutic use : Monoamine oxidase inhibitors : clinical pharmacology, benefits, and potential health risks / Sushil K. Sharma, Ph. D  2016 1
Monoamine oxidase -- Inhibitors -- Therapeutic use -- Side effects : Monoamine oxidase inhibitors : clinical pharmacology, benefits, and potential health risks / Sushil K. Sharma, Ph. D  2016 1
NAD-ADP-ribosyltransferase -- Inhibitors -- Therapeutic use : PARP inhibitors for cancer therapy / Nicola J. Curtin, Ricky A. Sharma, editors  2015 1
NAD-ADP-ribosyltransferase -- Inhibitors -- Therapeutic use -- Testing : PARP as a therapeutic target / edited by Jei Zhang  2002 1
 

Inhibitors, Neoplasm -- See Antineoplastic agents


  1
 

Inhibitors, Neovascularization -- See Angiogenesis Inhibitors


Agents and endogenous substances that antagonize or inhibit the development of new blood vessels 		  1
 

Inhibitors of bacterial cell wall synthesis -- See Bacterial cell walls Synthesis Inhibitors


  1
 

Inhibitors of Cyclin-Dependent Kinase 4 Proteins -- See Cyclin-Dependent Kinase Inhibitor Proteins


A group of cell cycle proteins that negatively regulate the activity of CYCLIN/CYCLIN-DEPENDENT KINASE complexes. They inhibit CELL CYCLE progression and help control CELL PROLIFERATION following GENOTOXIC STRESS as well as during CELL DIFFERENTIATION 		  1
 

Inhibitors of Poly(ADP-ribose) Polymerases -- See Poly(ADP-ribose) Polymerase Inhibitors


Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES 		  1
 

Inhibitors, PARP -- See Poly(ADP-ribose) Polymerase Inhibitors


Chemicals and drugs that inhibit the action of POLY(ADP-RIBOSE)POLYMERASES 		  1
Peptidase -- Inhibitors : Proteinase and peptidase inhibition : recent potential targets for drug development / edited by H. John Smith and Claire Simons  2002 1
Phosphodiesterases -- Inhibitors : Phosphodiesterases and their inhibitors / edited by Spiros Liras and Andrew S. Bell  2014 1
Phosphodiesterases -- Inhibitors -- Therapeutic use : Phosphodiesterases and their inhibitors / edited by Spiros Liras and Andrew S. Bell  2014 1
Phospholipase A2 -- Inhibitors. : Phospholipase A2 : basic and clinical aspects in inflammatory diseases / volume editors, W. Uhl, T.J. Nevalainen, M.W. Büchler  1997 1
Phosphoprotein phosphatases -- Inhibitors -- Handbooks, manuals, etc : Inhibitors of protein kinases and protein phosphataes / contributors, D.R. Alexander [and others] ; editors, Lorenzo A. Pinna and Patricia T.W. Cohen  2004 1
 

Inhibitors, Platelet -- See Platelet Aggregation Inhibitors


Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system 		  1
 

Inhibitors, Platelet Aggregation -- See Platelet Aggregation Inhibitors


Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system 		  1
 

Inhibitors, Proteasome -- See Proteasome Inhibitors


Compounds that inhibit the function or proteolytic action of the PROTEASOME 		  1
Add Marked to Bag Add All On Page Add Marked to My Lists
Result Page   Prev Next
Limit/Sort Search Search as Words